News archive
Thursday 12 June from 10:00 CET
CEO Gustav H. Gram will present and elaborate PILA PHARMA and the market for obesity and diabetes drugs. Furthermore, he will discuss the company’s outlook and plans for upcoming activities to generate more value adding data.
Wednesday 11 June from 11:00 CET
CEO Gustav H. Gram will participate in Swedish investment podcast 10X and elaborate about PILA PHARMA, its innovative pill and the market for obesity and diabetes drugs.
AktieInfo Investor Evening (Scandic Sydhavnen, Copenhagen, Denmark)
Monday, 19 May 2025 from 17:00 CEST
CEO Gustav H. Gram together with Founder & CSO Dorte X. Gram will attend and present PILA PHARMA at Aktieinfo’s annual event in Copenhagen, Denmark, elaborating on its innovative oral solution for treatment of obesity & diabetes.
Vator Life Science Summit (Stockholm, Sweden) (Invite only)
Wednesday, 14 May 2025 from 12:00 CEST
CEO Gustav H. Gram together with Founder & CSO Dorte X. Gram will present PILA PHARMA at this prominent investor event in Stockholm, Sweden, elaborating on its innovative oral solution for treatment of obesity & diabetes.
Malmömorgon (Slagthuset, Malmö, Sweden)
Monday 28 April 2025 from 07:00 CEST
Founder & CSO Dorte X. Gram will participate in a panel debate on creativity, entrepreneurial spirit and the courage to think ‘out of the box’.
Year-End Report Pila Pharma, 1 January – 31 December 2024
PILA PHARMA AB (publ) (FN STO: PILA) today publishes the Company´s
year-end report for the period January – December 2024.
The report can be found here
THE SPRINGTIME PARTNERING EVENT | Milan, Italy
(March 17–19, 2025)
PILA PHARMA will be represented by Founder, Chairman & CSO Dorte X. Gram as well as CEO Gustav H. Gram
PILA PHARMA H2 financial report presentation & Q&A (February 27 – 3PM CET)
Join the PILA PHARMA H2 online report call with Q&A.
Meet CEO Gustav H. Gram and CFO Hampus Darrell and ask your questions directly on the platform
